03/06/2026
π¨ IMPORTANT - ALERT FOR PATIENTS TAKING RAMIPRIL 2.5MG CAPSULES π¨
Some cartons of Ramipril 2.5mg Capsules, manufactured by Crescent Pharma Limited, may contain blister strips of Ramipril 10 mg Capsules and are being recalled at the pharmacy level as a precautionary measure.
If you were prescribed Ramipril 2.5 mg Capsules, and received a Crescent pack with batch number GR155023, please check the blister strips inside. The batch number and expiry date information can be found on the outer carton. Please see attached images for where to find this information, and what the different medication looks like.
β
IF the carton contains blister strips that are labelled as Ramipril 2.5 mg Capsules, you do not need to take further action and may continue to take the
capsules.
β IF the carton contains a blister strip that is labelled as Ramipril 10 mg capsules, DO NOT take the medicine, and contact your pharmacy
π€ If you are unsure or have any questions, please seek advice from your pharmacy or other healthcare professional responsible for your care
π΅βπ« IF you believe you have taken the Ramipril 10 mg Capsules and are currently experiencing any side effects such as feeling lightheaded, fainting, or being
fatigued, then please seek immediate medical advice. Please take the leaflet that came with your medicine and any remaining capsules with you to your pharmacy or GP practice.
Both strengths are used to treat high blood pressure, heart failure and kidney disease. Any possible impact of taking a higher dose of ramipril should be assessed by your healthcare professional to determine whether any examination or tests are needed.
For reference, the description of the products from the Patient Information Leaflets are as follows:
β
Ramipril 2.5 mg Capsules: Capsules are light grey and light green capsules,
marked with βRβ on the cap and β2.5β on the body.
β Ramipril 10 mg Capsules: Capsules are light grey and dark green capsules,
marked with βRβ on the cap and β10β on the body.
Images showing the different medicines and where to find the batch number of the product and the identification of the incorrect blister strip are below.
Patients who experience adverse reactions or have any questions about their medication should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme.
This is a NATIONWIDE alert - NOT specific to one pharmacy - so regardless of where you are in the UK, please check your medication.